FDA Orange Book · active-ingredient family
Cefoperazone sodium
Cefoperazone sodium is approved as 2 brand and 1 generic application in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:CEFOBID IN PLASTIC CONTAINER · NDA 050613
2
Brand (NDA)
1
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · injectable
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| CEFOBID IN PLASTIC CONTAINER×2 | PFIZER | NDA 050613 | — | Jul 31, 1987 | |
| CEFOBID×3 | PFIZER | NDA 050551 | — | Nov 18, 1982 |
Generic (ANDA) products (1)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| CEFOBID×2 | PFIZER | ANDA 063333 | — | Mar 31, 1995 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Cefoperazone sodium — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

